Amputation, Rehabilitation, Prosthetics, and Palliative Limb Care
Major amputation as a deliberate vascular endpoint rather than the opposite of vascular care: when an operation, endovascular procedure, primary amputation, rehabilitation pathway, or palliative limb plan is most likely to produce a healed, useful, goal-concordant outcome. The chapter frames level selection, prosthetic planning, and palliative limb care.
Multidisciplinary board: A board-room discussion with roles, escalation triggers, surveillance, patient goals, and what makes the pathway coherent.
Choose the hostsAmputation is a vascular decision
Major amputation is not the opposite of vascular care; it is one of its deliberate endpoints. In chronic limb-threatening ischemia and acute limb ischemia, the vascular surgeon must decide whether an operation, endovascular procedure, amputation, rehabilitation pathway, or palliative limb plan is most likely to produce a healed, useful, and goal-concordant outcome. Contemporary PAD and CLTI guidelines place primary amputation and palliation inside the same decision framework used for revascularization, particularly when the limb is unsalvageable, procedural risk is prohibitive, life expectancy is limited, or the expected functional benefit of salvage is poor.
- Treat major amputation as a deliberate, multidisciplinary CLTI decision: confirm anatomy, salvage attempts, infection control, and goals-of-care before proceeding.
- Trigger
- Adults with CLTI, severe foot infection, ALI, or failed limb-salvage attempts.
- Branch / Endpoint
- Framework-level guidance for primary-amputation and palliative-care triggers; recommendation grades differ between guideline societies
Citation - Apply the European framework: multidisciplinary CLTI review with explicit consideration of primary amputation and palliative limb care when revascularization is futile or against patient goals.
- Trigger
- Adults with CLTI or ALI under European guideline frameworks, including those approaching primary amputation or palliative care.
- Branch / Endpoint
- —
Citation - The Global Vascular Guidelines keep primary amputation and palliation inside the CLTI decision framework for patients with unsalvageable limbs, prohibitive risk, limited life expectancy, or poor expected functional benefit, rather than treating amputation as a failure outside vascular planning.
- Trigger
- Vascular patients
- Branch / Endpoint
- —
Citation
For surgical trainees, the first discipline is to stop treating amputation as a “failed salvage” label and instead document why a limb-salvage pathway is or is not anatomically, physiologically, and personally appropriate. The 2024 multisociety PAD framework expects amputation decision-making to sit within the broader CLTI pathway, with either limb-salvage attempts documented or anatomy and comorbidity recorded as reasons revascularization is not expected to succeed.
The second discipline is to define what “success” means before committing to another procedure. BEST-CLI and BASIL-2 show that, in contemporary distal CLTI, revascularization strategy affects trajectories that include major limb events, amputation, and death; these trials should make the surgeon cautious about offering repeated salvage attempts when the realistic endpoint is a nonhealing limb, a prolonged hospital course, or delayed amputation without meaningful recovery.
- Population
- Adults with CLTI and infrainguinal PAD, including those considered for primary amputation when limb-salvage success is uncertain.
- Intervention
- BEST-CLI MALE-or-death rates define the contemporary boundary at which limb-salvage attempts compete with primary or secondary amputation, interpreted with cohort-specific framing rather than pooled superiority claims.
- Comparator
- Endovascular revascularization
- Key result
- BEST-CLI Cohort 1 (n=1,420 with adequate single-segment great saphenous vein) at median 2.7-year follow-up reported a 42.6% surgical-arm and 57.4% endovascular-arm composite of major adverse limb event (which includes above-ankle amputation) or death, defining the contemporary boundary at which limb-salvage attempts compete with primary or secondary amputation
- Limitation
- Major adverse limb event definition includes above-ankle amputation and reintervention; numbers cannot be interpreted as pure amputation-rate estimates without parsing the disaggregated endpoint definition.
Citation- Population
- Patients with CLTI after infrainguinal revascularization where MALE and amputation endpoints frame limb-salvage outcomes.
- Intervention
- Use the MALE definition from BEST-CLI when discussing amputation outcomes after revascularization in the amputation chapter.
- Comparator
- BEST-CLI established MALE (major adverse limb event including amputation) as a composite endpoint, providing the framework for distinguishing limb-salvage success from progression to amputation.
- Key result
- MALE is a composite endpoint, so its components may not all carry equal clinical weight.
- Limitation
- Population
- Adults with CLTI requiring infra-popliteal revascularization; includes a subset who proceed to major amputation despite revascularization.
- Intervention
- In infra-popliteal CLTI, the choice between bypass-first and endovascular-first strategy directly shapes the amputation-or-death endpoint, with BASIL-2 favoring endovascular-first against BEST-CLI's surgical-first signal.
- Comparator
- 45% endovascular-first, illustrating that strategy choice in distal CLTI directl
- Key result
- BASIL-2 (n=345 with CLTI requiring an infra-popliteal revascularization) reported a composite of major amputation or death adjusted HR 1.35 favoring endovascular-first and mortality of 53% bypass-first vs 45% endovascular-first, illustrating that strategy choice in distal CLTI directly affects amputation-or-death trajectories
- Limitation
- European pragmatic trial; differs from BEST-CLI in anatomy and conduit-eligibility definitions. Do not merge BASIL-2 amputation rates with BEST-CLI Cohort 1 results.
Citation
The third discipline is to counsel with outcome ranges rather than reassurance. Population data show large variation in major lower-limb amputation incidence and early mortality across health systems, while contemporary amputation cohorts and systematic mortality syntheses support frank discussion that major lower-extremity amputation is a life-altering operation with substantial perioperative and long-term risk.
Risk prediction should support, not replace, judgment. AMPREDICT MoRe, using a large VA cohort of incident dysvascular amputees, reported 1-year outcomes of no death/no re-amputation in 57.7%, no death/re-amputation in 22.9%, death/no re-amputation in 14.3%, and both death plus re-amputation in 5.1%; its EHR-only model performed moderately overall and better for distinguishing no-event from both-event outcomes, but it remains a single-system, mostly male VA model and is not yet a bedside decision-support mandate.
Level selection must heal and function
Level selection is the central operative judgment in dysvascular amputation: the operation must remove the nonviable or nonfunctional limb segment, but the residual limb must also have a realistic chance of healing and supporting rehabilitation. Current rehabilitation guidance supports pre-amputation evaluation, prosthetic candidacy assessment, residual-limb planning, and longitudinal rehabilitation pathways, so the amputation level should be chosen with both wound healing and downstream function in view.
Through-knee and above-knee choices should be presented as distinct surgical strategies rather than interchangeable “major amputation” labels. Comparative outcomes work on through-knee versus above-knee amputation supports treating this as a specific technique and level-choice decision, especially when the patient’s rehabilitation potential, residual-limb needs, and probability of healing are being weighed.
The decision is rarely “lowest possible level” versus “highest safe level.” A distal level that preserves length but fails to heal may expose the patient to repeated operations, prolonged immobility, and delayed rehabilitation. Conversely, a more proximal level may heal more reliably but reduce functional potential. Re-amputation risk and timing are therefore not secondary details; they are part of the first consent conversation and should be incorporated into the level-selection discussion.
Best medical therapy does not stop at the amputation incision. The CLTI guidelines require antithrombotic therapy, lipid lowering, blood-pressure and glycemic control, counseling, exercise where appropriate, preventive foot care, and surveillance pathways across CLTI care, including patients who are not undergoing revascularization or who are approaching major amputation.
Recovery planning starts before discharge
Rehabilitation begins before the patient leaves the vascular service. A major amputation admission should include early identification of prosthetic candidacy, residual-limb needs, functional goals, discharge destination, and longitudinal rehabilitation follow-up; official rehabilitation guidance supports these pre-amputation, prosthetic, residual-limb, and long-term pathways.
The vascular surgeon’s role is to make the rehabilitation plan surgically coherent. The residual limb, wound-healing plan, medication plan, surveillance plan, and expected mobility pathway should be communicated before discharge so that rehabilitation teams are not forced to infer operative intent. Dysvascular rehabilitation cohort data support counseling patients that functional recovery and prosthetic training are realistic goals for selected patients, but not automatic outcomes for every patient after major amputation.
Discharge counseling should include the possibility of re-amputation and death within the first postoperative year. AMPREDICT MoRe provides a clinically useful way to discuss competing outcomes after incident dysvascular amputation: many patients avoid both death and re-amputation at 1 year, but a substantial minority experience re-amputation, death, or both. This framing helps trainees avoid presenting prosthetic rehabilitation as the only plausible postoperative story.
Perioperative pathways should be standardized where possible. Current vascular and enhanced-recovery consensus supports structured perioperative major-amputation care, which is useful for trainees because it shifts attention from the isolated operation to the entire episode: preoperative planning, postoperative recovery, discharge readiness, and rehabilitation continuity.
Secondary prevention remains part of recovery planning. After lower-extremity revascularization, VOYAGER PAD demonstrated that low-dose rivaroxaban plus aspirin reduced a composite of acute limb ischemia, major amputation for vascular causes, myocardial infarction, ischemic stroke, or cardiovascular death, while increasing ISTH major bleeding; for amputees with prior or concurrent revascularization, antithrombotic decisions should therefore be individualized within the broader vascular-risk and bleeding-risk plan rather than treated as a prosthetics issue alone.
- Official rehabilitation guideline supports pre-amputation, prosthetic candidacy, residual-limb and longitudinal rehab pathways.
- Action
- Interpret alongside anatomy, presentation, operative risk, and local practice before changing management.
- Clinical point
- Official rehabilitation guideline supports pre-amputation, prosthetic candidacy, residual-limb and longitudinal rehab pathways.
- Caveat
- Reflects guideline recommendations; consult the source guideline for exact class and level-of-evidence wording.
Citation - Current vascular/ERAS consensus supports perioperative major-amputation pathway content.
- Action
- Interpret alongside anatomy, presentation, operative risk, and local practice before changing management.
- Clinical point
- Current vascular/ERAS consensus supports perioperative major-amputation pathway content.
- Caveat
- Based on consensus rather than comparative trial evidence; consult the source for exact wording.
Citation
Palliative limb care is a positive care plan
Palliative limb care is not abandonment. It is an active plan for patients whose limb, physiology, prognosis, or goals make revascularization or major amputation unlikely to deliver a healed and useful outcome. Current PAD and CLTI frameworks explicitly include palliative care and shared decision-making when salvage attempts are unlikely to achieve a meaningful limb result.
A positive palliative limb plan should state what will be done, not only what will be avoided. The plan should identify the dominant problem—pain, tissue loss, infection risk, functional loss, treatment burden, or end-of-life priorities—and should align procedures, medications, wound care, and follow-up with the patient’s goals. Palliative-care consultation studies and end-of-life CLTI cohorts support building systems that make these conversations and care pathways available to frail CLTI patients rather than reserving them for the final hours of hospitalization.
- Observational cohort data; findings apply to end-of-life CLTI patients and may not generalise beyond that group.
- Clinical trigger
- End-of-life CLTI cohort adds palliative/outcomes evidence distinct from technical limb-salvage sources.
- Boundary
- Observational cohort data; findings apply to end-of-life CLTI patients and may not generalise beyond that group.
Citation - Based on a Medicare cohort; observational data do not establish causation and may not generalise to other populations.
- Clinical trigger
- Medicare cohort documents palliative-care underuse in CLTI, supporting non-procedure goals-of-care content.
- Boundary
- Based on a Medicare cohort; observational data do not establish causation and may not generalise to other populations.
Citation
Underuse of palliative care in CLTI is a systems failure, not a patient preference by default. Medicare data documenting palliative-care underuse support teaching trainees to introduce palliative care as an added layer of goal-focused support, especially when repeated revascularization, major amputation, or prolonged institutional care may be discordant with the patient’s priorities.
Quality of life is a legitimate endpoint in CLTI. Patient-reported outcome syntheses in CLTI support discussing limb care in terms of daily burden, function, symptoms, and treatment trade-offs, not simply patency, wound status, or amputation-free survival. Decision-aid work similarly supports explicit trade-off communication when patients are choosing between limb salvage, amputation, and nonoperative palliative pathways.
- Decision-aid source supports shared decision-making and trade-off communication for amputation decisions.
- Trigger
- Decision-aid source supports shared decision-making and trade-off communication for amputation decisions.
- Branch / Endpoint
- —
Citation - Quality of life in CLTI: systematic review and meta-analysis; primary evidence patient-reported-outcomes synthesis
- Trigger
- When weighing quality-of-life and palliative-care considerations in CLTI
- Branch / Endpoint
- Synthesis of patient-reported outcomes; findings apply to patients with CLTI and may not generalise beyond it.
Citation
The surgeon must still be precise about vascular options. A patient may decline revascularization, may be too frail for it, may have anatomy that makes it futile, or may face a limb that cannot become functional even if flow is improved. These are different clinical states and should be documented separately, because they shape whether the palliative plan includes observation, symptom-directed care, limited procedures, or major amputation for palliation.
Clinical integration, follow-up, and evidence boundaries
A coherent amputation pathway integrates five decisions: whether the limb can be salvaged, whether salvage would produce a useful limb, what level is most likely to heal and function, what rehabilitation pathway is realistic, and whether palliative limb care better matches the patient’s goals. These decisions should be made by a multidisciplinary team and documented as vascular decisions, not as isolated operative events.
Follow-up should be structured around failure modes. Early problems include wound failure, medical decompensation, and discharge-plan collapse; later problems include re-amputation, contralateral limb threat, loss of rehabilitation momentum, and cardiovascular events. Registry-derived risk models, contemporary major-amputation cohorts, and re-amputation studies support using follow-up to anticipate these outcomes rather than waiting for the patient to reappear through emergency care.
The contralateral limb and systemic vascular risk remain part of the same disease. CLTI best medical therapy, preventive foot care, and surveillance principles apply after amputation, and therapies with unestablished effectiveness as substitutes for revascularization should not distract from evidence-based vascular prevention, rehabilitation planning, and goal-concordant care.
- Adults with CLTI, severe foot infection, ALI, or failed limb-salvage attempts.
- Action
- Treat major amputation as a deliberate, multidisciplinary CLTI decision: confirm anatomy, salvage attempts, infection control, and goals-of-care before proceeding.
- Clinical point
- The 2024 ACC/AHA PAD guideline frames major amputation as a deliberate vascular decision within the CLTI and acute-limb-ischemia subsets, requires multidisciplinary team-based care, and emphasises shared decision-making and palliative care when salvage attempts are unlikely to create a healable or useful limb.
- Caveat
- Guidance is framework-level for primary-amputation and palliative-care triggers; recommendation grades differ between guideline societies
Citation - Official rehabilitation guideline supports pre-amputation, prosthetic candidacy, residual-limb and longitudinal rehab pathways.
- Action
- Interpret alongside anatomy, presentation, operative risk, and local practice before changing management.
- Clinical point
- Official rehabilitation guideline supports pre-amputation, prosthetic candidacy, residual-limb and longitudinal rehab pathways.
- Caveat
- Reflects guideline recommendations; consult the source guideline for exact class and level-of-evidence wording.
Citation - Current vascular/ERAS consensus supports perioperative major-amputation pathway content.
- Action
- Interpret alongside anatomy, presentation, operative risk, and local practice before changing management.
- Clinical point
- Current vascular/ERAS consensus supports perioperative major-amputation pathway content.
- Caveat
- Based on consensus rather than comparative trial evidence; consult the source for exact wording.
Citation
Trainees should understand the limits of the evidence they cite in consent. Trial composite endpoints are not pure amputation rates; BEST-CLI’s major adverse limb event framework includes above-ankle amputation and reintervention, while VOYAGER PAD’s limb benefit sits within a broader cardiovascular and limb composite. The correct bedside translation is not to quote these studies as direct predictors for an individual stump, but to use them to explain that revascularization, amputation, death, and major limb events compete in the same high-risk vascular population.
- Population
- Patients with CLTI after infrainguinal revascularization where MALE and amputation endpoints frame limb-salvage outcomes.
- Intervention
- Use the MALE definition from BEST-CLI when discussing amputation outcomes after revascularization in the amputation chapter.
- Key result
- BEST-CLI established MALE (major adverse limb event including amputation) as a composite endpoint, providing the framework for distinguishing limb-salvage success from progression to amputation
- Limitation
- MALE is a composite endpoint, so its components may not all carry equal clinical weight.
Citation
The final clinical habit is to make the plan reviewable. The chart should show the vascular indication, alternatives considered, reason salvage is being pursued or abandoned, amputation level rationale, rehabilitation expectations, medical-therapy plan, palliative-care involvement when appropriate, and follow-up triggers. This disciplined documentation protects the patient from fragmented care and helps the next clinician understand whether the goal is limb salvage, recovery after amputation, or comfort-focused limb care.
References
- 1.2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the management of lower extremity peripheral artery disease. Circulation. 2024.PubMed-indexed articleClinical practice guideline2024
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the management of lower extremity peripheral artery disease. Circulation. 2024. doi:10.1161/CIR.0000000000001251. PMID:38743805.
- 2.
- 3.
- 4.
- 5.
- 6.
- 7.
- 8.
- 9.
- 10.Through-knee versus above-knee amputation for vascular and non-vascular major lower-limb amputation. Cochrane Database Syst Rev. 2022.PubMed-indexed articleReview2022
Through-knee versus above-knee amputation for vascular and non-vascular major lower-limb amputation. Cochrane Database Syst Rev. 2022. doi:10.1002/14651858.CD013839.pub2. PMID:34904714.
- 11.Development of the AMPDECIDE Decision Aid to Facilitate Shared Decision Making in Patients Facing Amputation Secondary to Chronic Limb Threatening Ischemia. 2024.PubMed-indexed articleReview2024
Development of the AMPDECIDE Decision Aid to Facilitate Shared Decision Making in Patients Facing Amputation Secondary to Chronic Limb Threatening Ischemia. 2024. doi:10.1016/j.jss.2024.03.011. PMID:38714006.
- 12.Functional Outcomes After the Prosthetic Training Phase of Rehabilitation After Dysvascular Lower Extremity Amputation. 2015.PubMed-indexed articleRegistry / cohort2015
Functional Outcomes After the Prosthetic Training Phase of Rehabilitation After Dysvascular Lower Extremity Amputation. 2015. doi:10.1016/j.pmrj.2015.05.006. PMID:25978948.
- 13.End of life care in chronic limb threatening ischemia: A retrospective cohort study. 2024.DOI publisher routeRegistry / cohort2024
End of life care in chronic limb threatening ischemia: A retrospective cohort study. 2024. doi:10.1016/j.jvsvi.2024.100141.
- 14.A framework for perioperative care in lower extremity major limb amputation: a consensus statement by the Enhanced Recovery After Surgery (ERAS) Society and Society for Vascular Surgery. 2024.DOI publisher routeClinical practice guideline2024
A framework for perioperative care in lower extremity major limb amputation: a consensus statement by the Enhanced Recovery After Surgery (ERAS) Society and Society for Vascular Surgery. 2024. doi:10.1016/j.jvsvi.2024.100156.
- 15.Major lower extremity amputation: a contemporary analysis from an academic tertiary referral centre in a developing community. 2019.PubMed-indexed articleRegistry / cohort2019
Major lower extremity amputation: a contemporary analysis from an academic tertiary referral centre in a developing community. 2019. doi:10.1186/s12893-019-0637-y. PMID:31722699.
- 16.Integration of palliative care consultation into the management of patients with chronic limb-threatening ischemia. 2023.PubMed-indexed articleRegistry / cohort2023
Integration of palliative care consultation into the management of patients with chronic limb-threatening ischemia. 2023. doi:10.1016/j.jvs.2022.12.069. PMID:37088444.
- 17.A single center's 15-year experience with palliative limb care for chronic limb threatening ischemia in frail patients. 2022.PubMed-indexed articleRegistry / cohort2022
A single center's 15-year experience with palliative limb care for chronic limb threatening ischemia in frail patients. 2022. doi:10.1016/j.jvs.2021.09.032. PMID:34627958.
- 18.Poor utilization of palliative care among Medicare patients with chronic limb-threatening ischemia. 2023.PubMed-indexed articleRegistry / cohort2023
Poor utilization of palliative care among Medicare patients with chronic limb-threatening ischemia. 2023. doi:10.1016/j.jvs.2023.02.023. PMID:37088446.
- 19.Clinical Practice Guidelines for the Rehabilitation of Lower Limb Amputation: An Update from the Department of Veterans Affairs and Department of Defense. 2019.PubMed-indexed articleClinical practice guideline2019
Clinical Practice Guidelines for the Rehabilitation of Lower Limb Amputation: An Update from the Department of Veterans Affairs and Department of Defense. 2019. doi:10.1097/PHM.0000000000001213. PMID:31419214.
- 20.Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. Eur J Vasc Endovasc Surg. 2019.DOI publisher routeClinical practice guideline2019
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. Eur J Vasc Endovasc Surg. 2019. doi:10.1016/j.ejvs.2019.05.006.
- 21.
- 22.Bradbury AW, Moakes CA, Popplewell M, et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet. 2023;401(10390):1798-1809.PubMed-indexed articleRandomized controlled trial2023
- 23.
- 24.
Educational use only
AI assists this editorial workflow. Published updates are human-reviewed before publication.
Not intended to diagnose, monitor, predict, prognose, treat, or alleviate disease.
Verify clinically relevant information against primary sources and current guidelines.